Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA

…, YC Kim, A Reyes-Sandoval, FG da Fonseca - Viruses, 2020 - mdpi.com
Chikungunya virus (CHIKV) is a mosquito-borne pathogen that causes a disease characterized
by the acute onset of fever accompanied by arthralgia and intense joint pain. Clinical …

[PDF][PDF] Protease inhibitors from Theobroma cacao impair SARS-CoV-2 replication in vitro

…, D de Sousa Lopes, FF Bagno, FG da Fonseca… - Heliyon, 2023 - cell.com
SARS-CoV-2 is a newly emerging virus from the Coronaviridae family that has already
infected over 700 million people worldwide and killed over 6 million. This virus uses protease …

Undetected Chikungunya virus co-infections in a Brazilian region presenting hyper-endemic circulation of Dengue and Zika

…, LC Godoi, FG da Fonseca - Journal of Clinical …, 2019 - Elsevier
Background Chikungunya virus (CHIKV) causes a disease characterized by acute onset of
fever accompanied by arthralgia. Clinical similarities and co-circulation of other arboviruses …

Design, development, and validation of multi-epitope proteins for serological diagnosis of Zika virus infections and discrimination from dengue virus seropositivity

…, FF Bagno, FG da Fonseca - PLOS Neglected …, 2024 - journals.plos.org
Zika virus (ZIKV), an arbovirus from the Flaviviridae family, is the causative agent of Zika fever,
a mild and frequent oligosymptomatic disease in humans. Nonetheless, on rare occasions…

Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine

…, AL Chaves Maia, EB Lages, FG da Fonseca… - …, 2023 - Future Medicine
Aim: To develop, characterize and evaluate an oil/water nanoemulsion with squalene (CTVad1)
to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials. Materials & …

SARS-CoV-2 rapid antigen test based on a new anti-nucleocapsid protein monoclonal antibody: development and real-time validation

…, CG Bomfim, CP Soares, CR Guzzo, FG Fonseca… - Microorganisms, 2023 - mdpi.com
SARS-CoV-2 diagnostic tests have become an important tool for pandemic control. Among
the alternatives for COVID-19 diagnosis, antigen rapid diagnostic tests (Ag-RDT) are very …

[PDF][PDF] Bioquímica nas escolas: uma estratégia educacional para o estudo de Ciência no Ensino Médio

…, BK de Menezes Dias, FF Bagno… - … ELO–Diálogos em …, 2016 - periodicos.ufv.br
… Lethícia Ribeiro Henriques1, Isaac Filipe Moreira Konig2, Bárbara Karina de Menezes
Dias3, Flávia Fonseca Bagno4, Raquel Cristina Vieira dos Santos5, João Paulo Viana Leite6 …

EVALUATION OF AN RBD-NUCLEOCAPSID FUSION PROTEIN AS A BOOSTER CANDIDATE FOR COVID-19 VACCINE

…, NS Hojo-Souza, MAA Dos Reis, FF Bagno… - iScience, 2024 - cell.com
Despite successful vaccines and updates, constant mutations of SARS-CoV-2 makes
necessary the search for new vaccines. We generated a chimeric protein that comprises the …

[HTML][HTML] Development of an enzyme-linked immunosorbent assay using recombinant protein antigen for the diagnosis of Chikungunya virus

…, MM Figueiredo, FG da Fonseca - Data in brief, 2019 - Elsevier
We describe here the development of an in-house enzyme linked immunosorbent assay (ELISA)
for the diagnostic of Chikungunya virus (CHIKV) infections using a recombinant protein …

Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or …

…, APSM Fernandes, SMR Teixeira, FG Fonseca - 2022 - arca.fiocruz.br
Objective: In this work, samples were selected from a cohort of patients infected with SARS-CoV-2
(n= 50) with mild to moderate symptoms, and from volunteers without a history of …